Report

Global Artificial Intelligence in Omics Studies Market Size Study, by Type, by Application, by Technology, by Offering and Regional Forecasts 2024-2032

  • Publish Date: Sep,2024
  • Report ID: 03-02-1931
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Global Artificial Intelligence in Omics Studies Market Executive Summary
1.1. Global Artificial Intelligence in Omics Studies Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Application
1.3.3. By Technology
1.3.4. By Offering
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Artificial Intelligence in Omics Studies Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Artificial Intelligence in Omics Studies Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Adoption of AI in Healthcare and Life Sciences Research
3.1.2. Rising Need for Customized Healthcare
3.1.3. Government Initiatives and Funding
3.2. Market Challenges
3.2.1. High Implementation Costs
3.2.2. Data Privacy and Security Concerns
3.3. Market Opportunities
3.3.1. Integration of AI in Various Omics Applications
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Artificial Intelligence in Omics Studies Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Artificial Intelligence in Omics Studies Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Artificial Intelligence in Omics Studies Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Genomics
5.2.2. Transcriptomics
5.2.3. Proteomics
5.2.4. Metabolomics
5.2.5. Epigenomics
Chapter 6. Global Artificial Intelligence in Omics Studies Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Artificial Intelligence in Omics Studies Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Clinical Diagnostics
6.2.2. Drug Discovery & Development
Chapter 7. Global Artificial Intelligence in Omics Studies Market Size & Forecasts by Technology 2022-2032
7.1. Segment Dashboard
7.2. Global Artificial Intelligence in Omics Studies Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Machine Learning
7.2.2. Deep Learning
7.2.3. Others
Chapter 8. Global Artificial Intelligence in Omics Studies Market Size & Forecasts by Offering 2022-2032
8.1. Segment Dashboard
8.2. Global Artificial Intelligence in Omics Studies Market: Offering Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Software
8.2.2. Services
Chapter 9. Global Artificial Intelligence in Omics Studies Market Size & Forecasts by Region 2022-2032
9.1. North America Artificial Intelligence in Omics Studies Market
9.1.1. U.S. Artificial Intelligence in Omics Studies Market
9.1.1.1. Type breakdown size & forecasts, 2022-2032
9.1.1.2. Application breakdown size & forecasts, 2022-2032
9.1.2. Canada Artificial Intelligence in Omics Studies Market
9.2. Europe Artificial Intelligence in Omics Studies Market
9.2.1. U.K. Artificial Intelligence in Omics Studies Market
9.2.2. Germany Artificial Intelligence in Omics Studies Market
9.2.3. France Artificial Intelligence in Omics Studies Market
9.2.4. Spain Artificial Intelligence in Omics Studies Market
9.2.5. Italy Artificial Intelligence in Omics Studies Market
9.2.6. Rest of Europe Artificial Intelligence in Omics Studies Market
9.3. Asia-Pacific Artificial Intelligence in Omics Studies Market
9.3.1. China Artificial Intelligence in Omics Studies Market
9.3.2. India Artificial Intelligence in Omics Studies Market
9.3.3. Japan Artificial Intelligence in Omics Studies Market
9.3.4. Australia Artificial Intelligence in Omics Studies Market
9.3.5. South Korea Artificial Intelligence in Omics Studies Market
9.3.6. Rest of Asia Pacific Artificial Intelligence in Omics Studies Market
9.4. Latin America Artificial Intelligence in Omics Studies Market
9.4.1. Brazil Artificial Intelligence in Omics Studies Market
9.4.2. Mexico Artificial Intelligence in Omics Studies Market
9.4.3. Rest of Latin America Artificial Intelligence in Omics Studies Market
9.5. Middle East & Africa Artificial Intelligence in Omics Studies Market
9.5.1. Saudi Arabia Artificial Intelligence in Omics Studies Market
9.5.2. South Africa Artificial Intelligence in Omics Studies Market
9.5.3. Rest of Middle East & Africa Artificial Intelligence in Omics Studies Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Pacific Biosciences of California, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Myriad Genetics, Inc.
10.3.3. BD (Becton, Dickinson and Company)
10.3.4. BioRad Laboratories, Inc.
10.3.5. Oxford Nanopore Technologies, PLC
10.3.6. PerkinElmer, Inc.
10.3.7. Agilent Technologies
10.3.8. Sequenom, Inc.
10.3.9. QIAGEN
10.3.10. Illumina, Inc.
10.3.11. Trimble Inc.
10.3.12. Abbott Laboratories
10.3.13. Thermo Fisher Scientific
10.3.14. Hoffmann-La Roche Ltd.
10.3.15. Novogene Co., Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes